News

Following the success of Humulin, recombinant DNA technology was quickly adopted to replace older methods of producing medical products from human growth hormone to vaccines. Although scientists have ...
Recombinant DNA can treat bleeding disorders ... Recombinant human growth hormone can be used to treat this deficiency. Vaccines do more than protect the lives of individuals; they protect ...
Current techniques of gene transfer in mammals include packaging the DNA into recombinant viral vectors ... to test if they have created an effective vaccine. In addition, naked DNA vaccines ...
Live attenuated vaccines have saved millions of lives ... Specifically, the authors used recombinant DNA technology to produce a poliovirus in which the 5′-most coding sequence, for the capsid ...
One focus was multivalent vaccines that could prime the ... had made the first recombinant DNA breakthrough in 1973. By 1998, the program had scientists working on 43 different projects.
are not subject to the NIH Guidelines unless the transposon itself contains recombinant DNA. Investigators apply to the IRB for this exemption by completing the Protocol Oversight Review Form—For HIV ...
These responses are five- to tenfold higher than the T-cell responses induced by the DNA vaccine or recombinant MVA vaccine alone, and produce partial protection manifest as delayed parasitemia ...
Vaccines Tobacco Hepatitis B virus surface ... for Economic Cooperation and Development (OECD), called "Recombinant DNA Safety Considerations," became the first intergovernmental document to ...
These Biosafety–Recombinant and Synthetic DNA policies and procedures exist to ensure that all research and activities involving the use of altered or synthetic and potentially hazardous DNA or RNA ...